The extracellular matrix (ECM) is a fundamental component of multicellular organisms that orchestrates developmental processes and controls cell and tissue organization. Mutations in ECM genes or changes in ECM composition, architecture or abundance have been shown to cause or accompany a plethora of diseases including fibrosis, renal, skeletal and vascular diseases and cancers. We previously identified the ECM protein SNED1 in a proteomic screen comparing the ECM of highly and poorly metastatic human mammary tumor xenografts. We further showed that SNED1 promoted breast cancer metastasis and that its level of expression correlated with survival of breast cancer patients. Here we sought to identify the roles of Sned1 during murine development and physiology. Employing a gene-trap strategy or the introduction of a frameshift mutation, we generated two novel Sned1 knockout mouse strains.
Introduction
The extracellular matrix (ECM) is a fundamental component of multicellular organisms. It is a complex and dynamic assembly of hundreds of proteins that provides support to cells and instructs their behaviors (1) (2) (3) . Knockout mouse models have allowed identification of the instrumental roles of ECM proteins and ECM-protein receptors at multiple steps of embryonic development (4) (5) (6) (7) . SNED1 (Sushi, Nidogen and EGF-like Domains 1), initially named SNEP (Stromal Nidogen Extracellular matrix Protein), encodes a secreted protein composed of characteristic domains commonly found in ECM proteins (8, 9) including an amino-terminal NIDO domain, 15 EGF-like and calciumbinding EGF-like domains, one or two Follistatin-N-terminal-like (FOLN) domains, (depending on the prediction algorithms (10, 11) ), a Complement Control Protein (CCP, also known as Sushi domain), and three Type III fibronectin (FN3) domains in the carboxy-terminal region of the protein ( Fig 1A) .
Interrogation of gene and protein databases revealed that orthologues of SNED1 are found in all sequenced vertebrates, including fish, reptiles, amphibians, birds, and mammals ( Fig 1A) , but not in lower organisms. Of note, the evolution of vertebrates and mammals was accompanied by the expansion of families of ECM proteins existing in lower organisms (such as the collagens) and the appearance of novel ECM proteins (12) (13) (14) , such as SNED1. The increasing complexity of the ECM was concomitant with the appearance of novel structures including the neural crest in vertebrates and of mammary glands in mammals (15, 16 ) (see Conclusion).
The murine gene Sned1 was cloned by Leimeister and collaborators in 2004 from renal stromal cells (17) . In this original publication, the authors used in-situ hybridization to characterize the sites of expression of Sned1 at different time points during embryonic development. Their results showed that Sned1 is broadly expressed, mainly in ectoderm, neural-crest, and mesoderm derivatives including kidneys, adrenal glands, lungs, skeleton, limbs, and the head region (17) . However, until recently, no function for Sned1 had been reported.
In a proteomic screen comparing the ECM composition of poorly and highly metastatic human mammary tumors, we identified SNED1 as being more abundant in more aggressive mammary tumors (18) . We further showed that it was produced by mammary tumor cells and not by the stromal cells of the tumor microenvironment, and identified the first function of this protein as a metastatic promoter, since knocking down SNED1's expression in tumor cells prevented metastasis (18) . We further demonstrated that SNED1 expression level was predictive of survival of hormone-receptor negative breast cancer patients (18) . Sned1 was found to be up-regulated in murine pancreatic ductal adenocarcinoma (PDAC) cells cultured in a 3-dimensional ECM and which are more resistant to chemotherapeutic drugs, as compared to cells grown on a 2-dimensional substrate (19) . Sned1 knockdown was also shown to inhibit mutant-p53-driven murine PDAC cell invasion in vitro (20) .
However, up to now, no functions have been identified for SNED1 in embryonic development or physiology. To address this, we aimed to knock-out Sned1 in mice. Sned1 was targeted using the "knockout-first allele" construct designed through an effort supported by the Wellcome Trust Sanger Institute and the Knockout Mouse Project (21) . Sned1 knockout was achieved using two approaches, a gene-trap strategy and a frameshift mutation strategy ( Fig 1B) . We also generated a conditional knockout mouse which will be useful in the future to determine the function of Sned1 in a cell-or time-specific manner. Using these novel mouse models, we demonstrate that Sned1 is an essential gene, since Sned1 knockout causes early neonatal (p0 -p2) lethality. Over the course of our studies, we obtained a few homozygous knockout mice which were distinguishable from wild-type and heterozygous littermates by their smaller size and craniofacial malformations, demonstrating that Sned1 plays significant roles during embryonic development. We propose that altered craniofacial structures might be a potential explanatory factor in the early neonatal lethality of Sned1 knockout mice.
Materials and methods

Generation of Sned1 knockout mice
All experiments involving mice were conducted in conformity with animal protocols approved by MIT's
Department of Comparative Medicine and Committee on Animal Care, and by the Committee on Animal
Care of the University of Illinois at Chicago in compliance with IACUC guidelines.
Two targeted Sned1 tm1a(KOMP)Wtsi ES cell clones (EPD0300_5_02 E02 and F01) from the C57BL/6 JM8.N4 parental ES cell line generated by the Wellcome Trust Sanger Institute (21) were obtained from the KOMP Repository (www.komp.org) at UC Davis and cultured on feeder cells using the recommended media including the 2i additives MEK inhibitor PD0325901 and GSK3 inhibitor CHIR99021 (StemGent). Three subclones of each clone were sent to Cell Line Genetics (Madison, WI) for cytogenetic analysis and two subclones of the targeted clone E02 were found to have an apparently normal mouse male karyotype. Cells from subclone E02-2D2 were microinjected into BALB/c blastocysts obtained from natural matings as previously described (22) . 10 recipient females each received 14 embryos. 7 pregnant females gave birth to 41 pups, of which 6 showed at least 70% dark coat color against white, BALB/c fur, and allowed establishment of the Sned1 tm1a(KOMP)Wtsi (referred to as Sned1 LacZ-Neo ) mouse line. B6.Cg-Tg(ACTFLPe)9205Dym/J (Actin-Flp; Jackson Laboratory stock No. 005703) mice allowing the ubiquitous expression of the Flp recombinase were obtained from MIT's transgenic core facility and were used to generate the Sned1 floxed Sned1 tm1c(KOMP)Wtsi allele, referred to as the Sned1 fl allele. B6.C-Tg(CMV-cre)1Cgn/J (CMV-Cre) mice allowing the ubiquitous expression of the Cre recombinase were purchased from Jackson Laboratory, stock No. 006054 and were used to generate the null Sned1 tm1d(KOMP)Wtsi allele, referred to as the Sned1allele. Figure 1B shows a schematic view of the alleles. The three mouse strains generated for this study have been deposited to Jackson laboratory: Sned1 LacZ-Neo stock No. 032246, Sned1 fl stock No. 032247, and Sned1stock No. 032248 and will be made available upon publication of this manuscript.
Genotyping
DNA was extracted from tail samples from 14-day old pups, or from yolk sacs or tail samples from E18.5 embryos, according to standard procedures and genotyping was performed with the following primers: 
Isolation of mouse embryonic fibroblasts and quantitative PCR
Mouse embryonic fibroblasts (MEFs) were isolated from E13.5 to E15.5 embryos obtained by timed mating of heterozygous Sned1 WT/LacZ-Neo mice. For quantitative PCR (qPCR), RNA was isolated from the cells using the RNeasy kit (Qiagen, Germantown, MD) and cDNA was synthesized by reverse transcription using the First-Strand cDNA Synthesis Kit (Promega, Madison, WI). qPCR reactions were performed using Bio-Rad SYBR Green Supermix (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. PCR conditions were 95°C for 10 minutes, followed by 40 cycles of 95°C for 20 seconds, 58°C for 30 seconds, and 72°C for 30 seconds. qPCR data analysis was performed using Bio-Rad CFX Manager Software. The following primers were used: Actin_F:
TGTATGAAGGCTTTGGTCTCC;
Actin_R; GTCTCAAGTCAGTGTACAGGC; Sned1_F:
GTAGATGGAAGAGGAAGAGTGAG; Sned1_R CTGTTCTTGGGTAGCTGGAG.
Statistical analysis
Goodness-of-fit analysis was performed using a two-tailed chi-square ( 2 ) test (GraphPad). This statistical analysis compares expected (Mendelian distribution) and observed numbers of embryos (E18.5) or pups (p21) to determine whether survival correlates with animal genotypes.
-galactosidase assay
-galactosidase assay (LacZ staining) was performed on whole heterozygous Sned1 WT/LacZ-Neo embryos (E11.5 and E13.5) according to previously published detailed protocols (23, 24) . For visualization of whole-mount staining, embryos were cleared by incubation in solutions of increasing glycerol and decreasing potassium hydroxide concentrations following a published protocol (25) . LacZ-stained embryos were embedded in paraffin and sectioned, sections were then dewaxed and rehydrated, and hematoxylin and eosin counter-staining was performed following standard procedures.
Microcomputed tomography image acquisition and analysis
An eXplore CT 120 microcomputed tomography (CT) system (Northridge Tri-Modality Imaging Inc., Chatsworth, CA) was used for in-vivo imaging. Mice were imaged under anesthesia (induced at 3% isoflurane in oxygen, maintained at between 2-2.5% during imaging) in groups of 4 in a custom mouse holder. Scanner settings were as follows: 720 views, 360-degree rotation, 70 kVp, 50 mA, 32 ms integration time with 2x2 detector pixel binning (isotropic nominal resolution of 50 microns).
Data were reconstructed using the Parallax Innovations (Ilderton, ON Canada) GPU accelerated reconstruction engine for the eXplore CT120. Reconstructed CT scans of the mouse crania were converted to TIFF files and imported into 3D Slicer or ImageJ for further analysis.
Measurement of cranial suture length
Variations in the cranial sutures were visually observed in 3D Slicer (26, 27) . The nasal, frontal, and sagittal sutures were observed through the transverse plane and were measured antero-posteriorly (in mm), while the coronal sutures were observed through the sagittal plane.
Landmarking and geometric morphometrics
We selected a total of 30 landmarks (22 traditional coordinate landmarks, 8 sliding semi-landmarks) which were deemed to represent well overall cranial morphology ( Supplementary Fig 4) . The 8 sliding semi-landmarks were positioned along the nasal suture, as visual observation indicated that nasal and mid-facial morphology may be particularly affected in these mice. To undertake complex phenotyping, we used standard geometric morphometric (GM) methodologies for analyzing 3D shapes. First, a generalized Procrustes analysis (GPA) was run on the raw coordinate landmark data. This procedure scales, rotates, and translates landmark data to align them for further analysis. Importantly, this step (through scaling) reduces size to a separate variable so that shape can be studied in isolation (28) . Semilandmarks were slid, minimizing bending energy, as a part of the GPA. Next, to investigate shape variation in the cohort, we ran a principal components analysis (PCA) on the GPA data. This yielded 19
principal components (PCs), the first four of which each represented >5% of the overall variation, and thus were chosen for further study (28) . Statistical significance of each of the first four PCs was assessed using a one-way non-parametric Kruskal-Wallis analysis of variance (ANOVA) by genotype (Sned1 WT/WT , Sned1 WT/LacZ-Neo , Sned1 LacZ-Neo/LacZ-Neo ) followed by a Tukey honest significant difference (HSD) test.
Assessment of nasal cavity symmetry and occlusion
Analyses were conducted using ImageJ software, using the "Multi VFF Opener" plug-in to open the CT scan files. Variations in nasal cavity symmetry and occlusion were visually observed in 3D Slicer (26, 27) and scored.
Results
Sned1 knockout results in early neonatal lethality
Sned1 knockout was achieved using an IRES:LacZ-trapping cassette (21) inserted in the second intron of Sned1 ( Fig 1B) . Decreased expression of Sned1 was confirmed using RT-qPCR on RNA extracted from mouse embryonic fibroblasts generated from Sned1 WT/WT , Sned1 WT/LacZ-Neo , Sned1 LacZ-Neo/LacZ-Neo mice ( Supplementary Fig 1) .
We attempted to obtain homozygous knockout mice (Sned1 LacZ-Neo/LacZ-Neo ) by intercrossing heterozygous (Sned1 WT/LacZ-Neo ) mice. We examined 55 litters born from 16 different breeding pairs of heterozygous mice (representing a total of 334 pups, of which 202 were still alive at weaning). We observed that a significant number of pups died within 48 hours after birth, and, when carcasses could be retrieved for genotyping, we found that the majority of dead neonates were knockout animals. We further observed that at weaning (p21 +/-1 day), knockout mice were present in sub-Mendelian ratios ( 2 =20.303; twotailed p<0.0001) (Table 1) . However, Mendelian ratios were observed for E18.5 embryos obtained by C-section (6 litters analyzed,  2 =1; two-tailed p=0.60605), suggesting that lethality of knockout pups occurred either around or shortly after birth (Table 1) . We then generated a conditional knockout mouse strain by crossing heterozygous Sned1 WT/LacZ-Neo mice with mice expressing the Flp recombinase under the control of the actin promoter. This resulted in the excision of the IRES: LacZ and Neo cassettes, and the generation of a floxed allele (Sned1 fl , Fig 1B) .
We further crossed conditional knockout mice with mice expressing the Cre recombinase under the control of a CMV promoter to obtain a null allele (Sned1 -, Fig 1B) . Heterozygous mice (Sned1 WT/-) were further intercrossed to generate homozygous null mice (Sned1 -/-). We evaluated 13 litters born from 7 different breeding pairs of heterozygous mice (representing a total of 88 pups, of which 63 were still alive at weaning). Similarly to what we observed with the gene-trap allele, a significant number of pups died within 48 hours after birth. When carcasses were retrieved for genotyping, we found that the majority of dead neonates were Sned1 -/mice. We further observed that at weaning (p21 +/-1 day), null mice (Sned1 -/-) were present in sub-Mendelian ratios ( 2 =12.492; two-tailed p=0.0019), indicating that null pups had died before that ( Table 2) . 5 litters were harvested by C-section to examine a total of 44 E18.5 embryos. As observed for the Sned1 LacZ-Neo strain, Mendelian ratios were observed ( 2 =0.364;
two-tailed p=0.8338), indicating that lethality of null pups occurred around or shortly after birth (Table   2 ). Altogether, our data demonstrate that Sned1 knockout, achieved using two approaches, results in early neonatal lethality. Over the course of our study, a few knockout mice survived and we sought to characterize their phenotype to gain insight into the physiological roles of SNED1. Crossing of Sned LacZ-Neo/LacZ-Neo survivors revealed that surviving Sned1 knockout mice were fertile although they produced less numerous and smaller litters. Pups obtained by breeding displayed exacerbated phenotypes (in particular, shorter snouts, under-developed mandibles) and only very few of their progeny survived after weaning.
Remarkably, the knockout survivors (either Sned LacZ-Neo/LacZ-Neo or Sned1 -/-) were distinguishable from wild-type and heterozygous littermates by their smaller size and the shape of their head and snout.
Sned1 knockout results in growth defects
Knockout survivors (either Sned LacZ-Neo/LacZ-Neo or Sned1 -/-) were smaller than wild-type and heterozygous littermates (Fig 2A) . At p14, knockout pups weighed significantly less than wild-type and heterozygous littermates ( Fig 2B and Supplementary Fig 2A) . This reduced body weight was readily detectable in p0.5 neonates ( Fig 2C) . Interestingly, we also observed that no milk was present in the stomachs of p0.5 knockout neonates whereas milk was present in wild-type and heterozygous littermates ( Fig 2D) .
Together with the observation that some neonates presented under-developed mandibles (Fig 2E) , we can hypothesize that the observed reduced body weight and neonatal lethality could be attributed, in part, to a decreased ability of knockout pups to suckle or ingest milk.
Sned1 is expressed in skeletal and craniofacial precursors.
We took advantage of the LacZ reporter gene expressed under the control of the Sned1 promoter to determine in which tissues Sned1 was expressed during development. Whole-mount LacZ staining revealed that the Sned1 promoter is broadly active at the two time-points examined, embryonic days 11.5
( Fig 3A) and 13.5 (Fig 3C) . At E11.5, LacZ staining was observed in mesodermal derivatives including the ventro-medial cells of the somites (Figs 3A and 3C) which will undergo epithelial-to-mesenchymal transition (EMT) to form the sclerotomes which will, in turn, give rise the vertebrae and the ribs. LacZ staining was also detected in the pharyngeal arches (29) (Fig 3B) , structures originating from the cephalic neural crest cells (NCC), which also undergo EMT when they detach from the neural tube, and will give rise to precursors of the nose, mandible (Meckel's cartilage) and tongue (visible at E13.5, Fig 3E) . In addition, staining was detected in the lung buds ( Fig 3C, right panel) , as previously reported (17) 
Sned1 knockout mice present cranial bone malformations
In addition to their small size, we observed that the knockout survivors were also distinguishable from wild-type and heterozygous littermates by their shorter snouts and abnormal head shape ( Fig 4A) .
Because Sned1 is expressed in structures that give rise to the craniofacial bones and cartilage, we sought to examine the skulls of wild-type, heterozygous and Sned1 knockout mice using micro-computed tomography (CT) ( Fig 4A) . We measured the length of the different calvarial sutures ( Supplementary   Fig 3A) including the nasal (anterior tip of nasal bones to premaxillary suture; Fig 4B) , frontal (premaxillary suture to coronal suture; Supplementary Fig 3B) , and sagittal suture (coronal to interparietal suture; Supplementary Fig 3C) . Knockout mice showed statistically significantly shorter nasal sutures as compared to wild-type (p=0.0036) or heterozygous (p=0.0051) mice ( Fig 4B) . Neither frontal nor sagittal sutures showed statistically significant differences between groups, although, in both cases, there was a trend towards shorter sutures in the knockout group ( Supplementary Figs 3B and 3C ).
We further employed geometric morphometric analysis to quantify complex 3D phenotypic variations in craniofacial morphology between mice of different genotypes ( Supplementary Fig 4) . Principal component analysis identified one component (PC1) which represents 30.05% of the overall variation and describes differences in cranial vault shape and nasal bridge morphology. PC1 showed statistically significant differences across the three groups (p=0.027, Fig 4C) . Animals at the maximum extreme of variation along PC1 (PC1 max, wild-type and heterozygous mice) tended to show relatively flatter (supero-inferiorly) and medio-laterally narrower neurocrania, narrower midfaces (at the zygoma), and convexity of the nasal bridge. Those at the minimum extreme of variation along PC1 (PC1 min, knockout mice), in contrast, showed concavity of the nasal bridge, relatively shorter snouts, wider faces and neurocrania, and more supero-inferiorly expanded neurocrania ( Fig 4D) .
A Tukey HSD test revealed that the overall statistical significance in PC1 was driven by differences between the wild-type and knockout groups (p=0.048) and between the heterozygote and knockout groups (p=0.017) while the comparison of the heterozygous and wild-type mice was not statistically significantly different (p=0.99) ( Fig 4E) . Although the mechanism by which Sned1 controls nasal bridge formation remains unknown, we can hypothesize that it results from a weakening of the nasal septum, the cartilaginous structure that supports the ossified nasal bridge.
Sned1 knockout mice present asymmetrical and occluded nasal cavities
The observation that Sned1 is expressed in structures giving rise to the nose ( Fig 3B) and that Sned1 knockout mice present nasal bridge collapse (Fig 4A, arrow) prompted us to further evaluate the anatomy of the nasal cavity of the animals. We observed that the three knockout neonates (p0.5) presented at least partial nasal occlusion, defined as a contact between the soft tissues forming the wall of the airways, whereas none of the wild-type animals presented occlusion (Fig 4F, Supplementary Files 1, 2, and 3 ). In the cohort of adult mice, 2 out of the 5 knockout mice presented markedly asymmetrical nasal cavities, whereas 9 out of 10 heterozygous and all 4 wild-type mice had symmetrical cavities (Fig 4G,   Supplementary Files 4, 5, and 6 ). In addition, 2 out of the 5 knockout mice presented partial occlusion, in contrast to all wild-type and heterozygous mice which presented no occlusion. Together with nasal obstruction, these observations support the hypothesis that the Sned1 knockout neonates may not survive because of impaired nasal respiration.
Discussion and conclusions
Here we report the generation of Sned1 knockout mice and their phenotypic analysis. We showed that Sned1 is essential during development, since most knockout mice die prematurely within 2 days of birth and the few surviving animals exhibit severe growth defect and craniofacial malformations. It is worth noting that the adult mice on which the phenotypic analyses were conducted are likely to present less severe phenotypes because they survived. Follow-up studies are now required to understand which compensatory mechanisms intervened and led to certain animals surviving whereas the majority of Sned1 knockout neonates did not survive past post-natal day 2. Of note, despite the broad pattern of expression of Sned1 in murine embryos, the only phenotypes discerned in this study relate to overall growth and craniofacial features. The surviving Sned1 knockout adults did not present other overt anomalies. In addition, morphological and histological analysis of two litters of p.0.25 neonates (including two knockout animals) and of some of the knockout pups that were found dead did not reveal gross anomalies in tissues apart from the head and tail regions (data not shown).
Further investigations are also required to decipher the precise cellular and molecular mechanisms controlled by Sned1 and underlying growth defect and craniofacial morphogenesis. We previously discovered SNED1 as an ECM protein promoting breast cancer metastasis (18) . Here, we report the expression of Sned1 during embryonic development in structures that will undergo epithelial-tomesenchymal transition (EMT), including the sclerotomes or have undergone EMT, such as the neuralcrest derivatives (32) . The parallel has been drawn between developmental EMT and carcinoma metastasis, since in both cases, epithelial cells lose cell-cell junctions, up-regulate ECM genes such as fibronectin, remodel their adhesions to the ECM and acquire a migratory phenotype (33, 34) . It would thus be interesting to determine whether SNED1 regulates this process both in development and in cancer.
Sequence analysis revealed that orthologues of Sned1 are found in all sequenced vertebrates, but not in lower organisms (Fig 1A) . In addition, two consensus potential binding sites (RGD and LDV, Fig 1A) for integrins (35, 36) , which are known ECM protein receptors, are present in the amino-terminal region of mammalian sequences of Sned1 (Fig 1A) , suggesting that the protein has further evolved, likely to support the development of mammalian-specific structures. One RGD motif is also found in the carboxyterminal region of the zebrafish sequence. It would thus be important to investigate whether the putative integrin-binding sites do engage these ECM receptors, and if so, if this is how Sned1 governs skeletal and craniofacial morphogenesis. It is also crucial to study both the signaling pathways regulating Sned1 and the pathways activated downstream of Sned1. Of note, Sned1 was among the most significantly up-regulated genes in neural-crest-cell-specific Tgfbr2 knockout mice (Tgfbr2 fl/fl ; Wnt1-Cre) presenting abnormal palate closure (clefting) (37) . Although cleft or lip palate were not observed in Sned1 knockout mice, this observation may suggest that Sned1 is regulated by the TGF signaling pathways. Future mechanistic investigations will benefit from the conditional Sned1 knockout mouse generated in this study which will be instrumental in determining the functions of Sned1 in a cell-or tissue-specific and time-specific manner. Further study of the roles of Sned1 in craniofacial development in mice may also shed light on fundamental processes that, when altered, lead to craniofacial malformations in humans (38) .
In humans, SNED1 is localized on the long arm of chromosome 2 (2q37.3). Deletion of 2q37 in human patients is characterized by mental retardation, facial dysmorphism and skeletal abnormalities including short stature (39-41). SNED1 had not been cloned when those studies were published. In light of the present study, it would be interesting to determine to what extent the craniofacial phenotype of 2q37 patients can be attributed to the loss of SNED1. B. Nasal suture length was measured from the anterior tip of nasal bones to premaxillary suture ( Supplementary Fig 3A) . Knockout mice (black triangles) showed statistically significantly shorter nasal sutures than wild-type (white circles; p=0.0036) or heterozygous (grey squares; p=0.0051) mice. 
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